1. Home
  2. BRSP vs ACHV Comparison

BRSP vs ACHV Comparison

Compare BRSP & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightSpire Capital Inc.

BRSP

BrightSpire Capital Inc.

HOLD

Current Price

$5.10

Market Cap

738.7M

Sector

Real Estate

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$6.68

Market Cap

618.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRSP
ACHV
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.7M
618.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
BRSP
ACHV
Price
$5.10
$6.68
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.50
$14.67
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
11.03%
N/A
EPS Growth
75.24
N/A
EPS
N/A
N/A
Revenue
$330,587,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.85
$2.38
52 Week High
$6.17
$7.11

Technical Indicators

Market Signals
Indicator
BRSP
ACHV
Relative Strength Index (RSI) 42.99 N/A
Support Level $4.85 N/A
Resistance Level $5.52 N/A
Average True Range (ATR) 0.14 0.00
MACD 0.00 0.00
Stochastic Oscillator 44.07 0.00

Price Performance

Historical Comparison
BRSP
ACHV

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: